We describe the case of a peripartum thrombotic thrombocytopenic purpura with fulminant cardiogenic shock treated with extracorporeal life support. Thrombotic thrombocytopenic purpura should be considered in the case of thrombotic microangiopathy with several or severe organ involvement and needs emergent treatment with plasmapheresis (with or without rituximab). In the case of cardiac involvement, aggressive treatment should be considered given the high mortality and the potential complete recovery.
CITATION STYLE
Champion, S., Belcour, D., & Gaüzère, B. A. (2020). Thrombotic thrombocytopenic purpura presenting as a severe peripartum cardiogenic shock: Role of myocardial biopsy and assist device for diagnosis and resuscitation. European Heart Journal: Acute Cardiovascular Care, 9(7), NP8–NP9. https://doi.org/10.1177/2048872617740829
Mendeley helps you to discover research relevant for your work.